Skip to content
OpenCapital
Get started

HCA Healthcare HCA Cash & Equivalents

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$4.95B+16.5%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
Universal Health Services logo
Universal Health ServicesUHS
$119.03M-6.1%
Community Health Systems logo
Community Health SystemsCYH
$149M-67.3%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$210.64M+149%
Acadia Healthcare logo
Acadia HealthcareACHC
$158.47M+73.7%

Other financials

Income statement

See full
Revenue$19.1B+4.3%
Net income$1.6B+0.6%
EPS (diluted)$7.15+10.9%

Balance sheet

See full
Total debt$49.8B+7.3%
Total equity-$6.3B-79.1%
Total assets$61.5B+2.8%

Cash flow

See full
Operating cash flow$2.0B+22.0%
CapEx$1.1B+12.9%
Free cash flow$895.0M+35.6%

Valuation

See full
Market cap$84.78B+3.5%
Enterprise value$133.69B+0.9%
P/E12.5×-1.2×
P/S1.1×0.0×

Profitability

See full
Net margin8.9%+0.8pp
FCF margin10.4%+3.5pp

Returns & leverage

See full
Return on equity-138.3%—
Debt / equity132.8×—
Current ratio0.8×-0.4×

Where this comes from

Reported directly by HCA Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: HCA Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about HCA Healthcare's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HCA Healthcare's cash & equivalents?
HCA Healthcare (HCA) reported cash & equivalents of $940M in Q1 2026.
How has HCA Healthcare's cash & equivalents changed year-over-year?
HCA Healthcare's cash & equivalents decreased by 11.3% year-over-year, from $1.06B to $940M.
What is the long-term trend for HCA Healthcare's cash & equivalents?
Over 5 years (2020 to 2025), HCA Healthcare's cash & equivalents has grown at a -10.3% compound annual growth rate (CAGR), from $1.79B to $1.04B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.